GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2. - Mizrahi RA; Lin WY; Gras A; Niedecken AR; Wagner EK; Keating SM; Ikon N; Manickam VA; Asensio MA; Leong J; Medina-Cucurella AV; Benzie E; et al. (Pathogens (Basel, Switzerland), 2022)